Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Performance of Primary Total Knee Arthroplasty Using Legion™ CR Oxinium and CoCr Femoral Implants Combined With Legion™/Genesis™ II XLPE High Flex Tibial Inserts

NCT03687593 is registered in ClinicalTrials.gov with Smith & Nephew, Inc. as lead sponsor.

NCT NCT03687593
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03687593 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Performance of Primary Total Knee Arthroplasty Using Legion™ CR Oxinium and CoCr Femoral Implants Combined With Legion™/Genesis™ II XLPE High Flex Tibial Inserts
Lead sponsor
Smith & Nephew, Inc.
Phase
Observational
Overall status
Active, not recruiting
Start date
August 26, 2018
Completion date
April 1, 2028
Enrollment
126 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

total knee arthroplasty